
2-Butoxyethyl 3-pyridinecarboxylate
Nicoboxil has been investigated for the treatment of Acute Low Back Pain, where it is typically considered an effective and safe therapeutic option. Nevertheless, it is predominantly found paired with nonivamide as a combination topical analgesic product where its proposed mechanism of action as a rubefacient is complementary and ultimately synergistic with nonivamide's capsaicin activity. Such combination topical analgesics are only available for purchase and use (for humans) in some parts of Europe and Asia, like Germany and Australia. Despite topical nicoboxil/nonivamide topical analgesic medication being used since the 1950s, recent studies demonstrate continued interest in the medication(s) given its demonstrated efficacy, safety, and capability to be used as an alternative musculoskeletal pain therapy option with less systemic side effects when compared to the oral non-steroidal anti-inflammatory drugs and opioids that may be more typically prescribed. — DrugBank
- IUPAC 명칭
- 2-butoxyethyl pyridine-3-carboxylate
- 분자식
- C12H17NO3
- 분자량
- 223.27 g/mol
- 정확한 질량
- 223.12084340 Da
- XLogP3
- 2.1
- 위상 극성 표면적
- 48.4 Ų
- 수소 결합 공여체
- 0
- 수소 결합 수용체
- 4
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEBI:CHEBI:32322
- ChEMBL:CHEMBL2105161
- EPA DTXSID:DTXSID4057635
- PubMed:28008281
- PubMed:25929250
- PubMed:19588430
- PubMed:13825636
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.